Living with lethal PIP3 levels: Viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB

被引:48
作者
Stocker, H
Andjelkovic, M
Oldham, S
Laffargue, M
Wymann, MP
Hemmings, BA
Hafen, E
机构
[1] Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland
[2] Friedrich Miescher Inst, CH-4058 Basel, Switzerland
[3] Univ Fribourg, CH-1700 Fribourg, Switzerland
关键词
D O I
10.1126/science.1068094
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The phosphoinositide phosphatase PTEN is mutated in many human cancers. Although the role of PTEN has been studied extensively, the relative contributions of its numerous potential downstream effectors to deregulated growth and tumorigenesis remain uncertain. We provide genetic evidence in Drosophila melanogaster for the paramount importance of the protein kinase Akt [also called protein kinase B (PKB)] in mediating the effects of increased phosphatidylinositol 3,4,5-trisphosphate (PIP3) concentrations that are caused by the loss of PTEN function. A mutation in the pleckstrin homology (PH) domain of Akt that reduces its affinity for PIP3 sufficed to rescue the lethality of flies devoid of PTEN activity. Thus, Akt appears to be the only critical target activated by increased PIP3 concentrations in Drosophila.
引用
收藏
页码:2088 / 2091
页数:4
相关论文
共 35 条
  • [11] Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway
    Goberdhan, DCI
    Paricio, N
    Goodman, EC
    Mlodzik, M
    Wilson, C
    [J]. GENES & DEVELOPMENT, 1999, 13 (24) : 3244 - 3258
  • [12] Shc and FAK differentially regulate cell motility and directionality modulated by PTEN
    Gu, JG
    Tamura, M
    Pankov, R
    Danen, EHJ
    Takino, T
    Matsumoto, K
    Yamada, KM
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 146 (02) : 389 - 403
  • [13] Huang H, 1999, DEVELOPMENT, V126, P5365
  • [14] Lawlor MA, 2001, J CELL SCI, V114, P2903
  • [15] Signalling through phosphoinositide 3-kinases: the lipids take centre stage
    Leevers, SJ
    Vanhaesebroeck, B
    Waterfield, MD
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) : 219 - 225
  • [16] Li DM, 1997, CANCER RES, V57, P2124
  • [17] PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
    Li, J
    Yen, C
    Liaw, D
    Podsypanina, K
    Bose, S
    Wang, SI
    Puc, J
    Miliaresis, C
    Rodgers, L
    McCombie, R
    Bigner, SH
    Giovanella, BC
    Ittmann, M
    Tycko, B
    Hibshoosh, H
    Wigler, MH
    Parsons, R
    [J]. SCIENCE, 1997, 275 (5308) : 1943 - 1947
  • [18] The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
    Maehama, T
    Dixon, JE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) : 13375 - 13378
  • [19] PTEN: a tumour suppressor that functions as a phospholipid phosphatase
    Maehama, T
    Dixon, JE
    [J]. TRENDS IN CELL BIOLOGY, 1999, 9 (04) : 125 - 128
  • [20] The PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptor-like signaling pathway
    Mihaylova, VT
    Borland, CZ
    Manjarrez, L
    Stern, MJ
    Sun, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) : 7427 - 7432